7th Webinar on Clinical Medicine
Updates on Leukemia in Children, Myelodysplastic Syndromes and Red Blood Cell Diseases
The webinar will discuss the advances which have been made over the years in the characterization and treatment of children leukemia. The detailed analysis of genetic alterations has identified subgroups of patients who will profit from adapted therapies including newer immunotherapeutic strategies using monoclonal antibodies, bispecific antibodies, immunotoxins, chimeric antigen receptor (CAR) T cells and allogeneic stem cell transplantation for front-line treatment and for relapses. Guidance will be given for the treatment of children with chronic myeloid leukemia (CML) and successful treatment strategies will be discussed for patients who live in countries with less resources and less access to all new therapeutic approaches. New developments will be discussed in the treatment of mainly elderly patients with myelodysplastic syndrome (MDS) based on the availability of next-generation sequencing (NGS). Patients’ with MDS and their unmet needs are reviewed, and a broader understanding of novel biological findings should lead to improve the health-related quality of life of these mainly elderly patients. Finally, hereditary diseases of red blood cells and especially the pathophysiology of erythropoiesis-related infectious diseases will be discussed, and a comprehensive review of diagnosis and therapy will be provided.
Date: 4 May 2022
Time: 9:00 am CEST | 3:00 am EDT | 3:00 pm CST Asia | 4:00 pm JST
Webinar ID: 837 8883 5086
Webinar Secretariat: jcm.webinar@mdpi.com